Evaluating Xerostomia as a side effect of [255Ac]Ac-PSMA therapy in prostate cancer : a systematic review and meta-analysis
dc.contributor.author | Al-Ibraheem, Akram | |
dc.contributor.author | Moghrabi, Serin | |
dc.contributor.author | Sathekge, Mike Machaba | |
dc.contributor.author | Abdlkadir, Ahmed Saad | |
dc.date.accessioned | 2025-05-06T04:35:13Z | |
dc.date.issued | 2025 | |
dc.description | DATA AVAILABILITY : The current study data are available from the corresponding author on reasonable request. | |
dc.description.abstract | Please read abstract in the article. | |
dc.description.department | Nuclear Medicine | |
dc.description.embargo | 2026-02-22 | |
dc.description.librarian | hj2023 | |
dc.description.sdg | SDG-03: Good heatlh and well-being | |
dc.description.uri | https://link.springer.com/journal/259 | |
dc.identifier.citation | Al-Ibraheem, A., Moghrabi, S., Sathekge, M.M. et al. Evaluating Xerostomia as a side effect of [255Ac]Ac-PSMA therapy in prostate cancer: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging (2025). https://doi.org/10.1007/s00259-025-07168-4. | |
dc.identifier.issn | 1619-7070 (print) | |
dc.identifier.issn | 1619-7089 (online) | |
dc.identifier.other | 10.1007/s00259-025-07168-4 | |
dc.identifier.uri | http://hdl.handle.net/2263/102297 | |
dc.language.iso | en | |
dc.publisher | Springer | |
dc.rights | © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025. The original publication is available at : http://link.springer.comjournal/259. | |
dc.subject | [225Ac]Ac-PSMA | |
dc.subject | Xerostomia | |
dc.subject | Dry mouth | |
dc.subject | Tandem | |
dc.subject | Targeted alpha therapy | |
dc.subject | Meta-analysis | |
dc.title | Evaluating Xerostomia as a side effect of [255Ac]Ac-PSMA therapy in prostate cancer : a systematic review and meta-analysis | |
dc.type | Postprint Article |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: